MedTrace Logo

Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions

NCT00552656 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2008-08-12

No results posted yet for this study

Summary

The purpose of this study is to investigate the long term efficacy and safety of firebird sirolimus-eluting stent for treatment of complex coronary Lesions.

Conditions

  • Coronary Disease

Interventions

DEVICE

Firebird(TM) Sirolimus-Eluting Stent

balloon expandable stent that made of stainless steel.The length is from 13mm-33mm,and the diameter from 2.5mm-4.0mm

Sponsors & Collaborators

  • Air Force Military Medical University, China

    collaborator OTHER

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    collaborator OTHER

  • Shanghai MicroPort Medical (Group) Co., Ltd.

    collaborator INDUSTRY

  • CCheart Consulting Co., Ltd.

    collaborator INDUSTRY

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Haichang Wang, MD,PhD · Director of Department of Cardiology of Xijing Hospital, Fourth Military Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2010-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00552656 on ClinicalTrials.gov